Search
moon
sun
๐Ÿ„

T220. Mushroom poisoning

A. Introduction

1.
๋…์„ฑ์˜ ์ •๋„๋Š” ์„ญ์ทจ๋Ÿ‰, ๋ฒ„์„ฏ์˜ ๋‚˜์ด, ๊ณ„์ ˆ, ์ง€๋ฆฌ์  ์œ„์น˜, ์กฐ๋ฆฌ ๋ฐฉ๋ฒ• ๋“ฑ์ด ์—ฐ๊ด€์ด ์žˆ๊ณ  ๋ฒ„์„ฏ์„ ์„ญ์ทจํ–ˆ์Œ ์—๋„ ๊ฐ๊ฐ์˜ ์‚ฌ๋žŒ๋งˆ๋‹ค ๋ฐ˜์‘์ด ๋‹ค๋ฅด๋‹ค. ๊ทธ๋ ‡๊ธฐ ๋•Œ๋ฌธ์— ๊ฐ™์€ ๋ฒ„์„ฏ์„ ๋จน์–ด๋„ ์–ด๋–ค ์‚ฌ๋žŒ์€ ์‹ฌํ•œ ์ฆ์ƒ์„ ๋ณด์ด๋‚˜ ์–ด๋–ค ์‚ฌ๋žŒ์€ ๋ฌด์ฆ์ƒ์ผ ์ˆ˜ ์žˆ๋‹ค.
2.
๋ฒ„์„ฏ์˜ ๋…์„ฑ์€ ์ดˆ๊ธฐ ๋…์„ฑ (์„ญ์ทจ ํ›„ 2์‹œ๊ฐ„ ์ด๋‚ด) ๋ฐ ์ง€์—ฐ ๋…์„ฑ (6์‹œ๊ฐ„~20์ผ) ์œผ๋กœ ๋‚˜๋‰œ๋‹ค
3.
์ฆ์ƒ์ด ์žˆ๋Š” ํ™˜์ž์˜ ๊ฒฝ์šฐ ์ž…์› ์น˜๋ฃŒ ํ•˜๋ฉฐ ํ‡ด์›์˜ ์ ์‘์ฆ์€ ์ฆ์ƒ์˜ ์†Œ์‹ค, ์žฅ๊ธฐ ์†์ƒ์ด ์—†๋Š” ๊ฒฝ์šฐ, ๋…๋ฒ„์„ฏ์ด ์•„๋‹Œ ๊ฒƒ์ด ํ™•์ธ๋œ ๊ฒฝ์šฐ์ž…๋‹ˆ๋‹ค.
4.
๋„ค ๊ฐœ์˜ ์ฃผ์š” ๊ตฐ์œผ๋กœ ์šฐ์—ฐํžˆ ์„ญ์ทจํ•œ ์–ด๋ฆฐ์ด, ์•ผ์ƒ ๋ฒ„์„ฏ ์ฑ„์ง‘์ž, ์ž์‚ด์ด๋‚˜ ์‚ด์ธ์— ์ด์šฉํ•˜๋Š” ์‚ฌ๋žŒ, ๊ฐ•ํ•œ ํ™˜๊ฐ์ œ๋ฅผ ์ฐพ๋Š” ์‚ฌ๋žŒ์œผ๋กœ ๋‚˜๋ˆŒ ์ˆ˜ ์žˆ๋‹ค.

B. Early onset GI symptom

1.
2 ์‹œ๊ฐ„ ์ด๋‚ด๋กœ ์„ค์‚ฌ (๋•Œ๋•Œ๋กœ bloody with fecal leukocytes ๋™๋ฐ˜), ๊ตฌํ† (๋•Œ๋•Œ๋กœ ์ด๋กœ ์ธํ•œ ํƒˆ์ˆ˜์™€ ์ „ํ•ด์งˆ ๋ถˆ๊ท ํ˜•์ด ๋ฐœ์ƒ ๊ฐ€๋Šฅ) ๋ฐ ๋ณตํ†ต์ด ๋ฐœ์ƒํ•˜๊ณ , ๋ณดํ†ต 24์‹œ๊ฐ„ ์ด๋‚ด์— ํ˜ธ์ „๋˜๋‚˜ ๊ฐ€๋”์€ ๋ฉฐ์น ์”ฉ ๊ฐ€๊ธฐ๋„ ํ•œ๋‹ค
2.
Activated charcoal (0.5~1.0g/kg, PO or NG tube)์„ ํˆฌ์—ฌํ•˜๊ณ  ํ•ญ๊ตฌํ† ์ œ๋Š” ๊ฐ€๋Šฅํ•˜๋‚˜ ์ง€์‚ฌ์ œ๋Š” ๋…์†Œ์— ๋Œ€ํ•œ ์ฆ์ƒ์ด ์ง€์†๋  ์ˆ˜ ์žˆ๊ธฐ ๋•Œ๋ฌธ์— ์‚ฌ์šฉํ•˜์ง€ ์•Š๋Š”๋‹ค.
3.
๊ตฌํ† ๊ฐ€ ํ˜ธ์ „๋˜๊ณ  ๋ฌผ์„ ๋งˆ์‹ค ์ˆ˜ ์žˆ์œผ๋ฉด ๋Œ€๋ถ€๋ถ„ ์‘๊ธ‰์‹ค์—์„œ ํ‡ด์‹คํ•œ๋‹ค
4.
์ฆ์ƒ์ด ์‹ฌํ•˜๋ฉด ์ˆ˜์•ก์น˜๋ฃŒ ๋ฐ ์ „ํ•ด์งˆ ๊ต์ •์„ ์œ„ํ•ด ๋“œ๋ฌผ๊ฒŒ ์ž…์›ํ•  ์ˆ˜ ์žˆ๋‹ค
5.
Outpatient ๋Š” 5์ผ ์ด๋‚ด ์™ธ๋ž˜ ์ถ”์ ์ง„๋ฃŒํ•˜๊ณ  ์†Œ๋ณ€์˜ ๋ณ€ํ™” ํ—ˆ๋ฆฌ๋‚˜ ์˜†๊ตฌ๋ฆฌ ํ†ต์ฆ ๋“ฑ์— ๋Œ€ํ•œ ์ฃผ์˜๋ฅผ ์ค€๋‹ค
6.
์‹ธ๋ฆฌ๋ฒ„์„ฏ, ๋ฌด๋‹น๋ฒ„์„ฏ, ์–ด๋ฆฌ์•Œ๋ฒ„์„ฏ, ์‚ฟ๊ฐ“์™ธ๋Œ€๋ฒ„์„ฏ, ๋…ธ๋ž€์ –๋ฒ„์„ฏ

C Early onset neurologic symptoms

โ€ข
์ผ๋ถ€ ๋ฒ„์„ฏ๋“ค์€ ์‹ ๊ฒฝํ•™์  ์ฆ์ƒ์„ ์œ ๋ฐœํ•˜๋Š”๋ฐ, psilocybin(CNS์˜ serotonergic neuron์— ์ž‘์šฉ )๋ฅผ ํ•จ์œ ํ•œ hallucinogenic mushroom๊ณผ isoxazole derivatives (GABA, anticholinergic effect)์„ ํ•จ์œ ํ•œ mushroom ์œผ๋กœ ๋‚˜๋‰œ๋‹ค

C1. Hallocinogenic mushroom

(1) ์ฆ์ƒ

โ€ข
์ „ํ˜•์ ์œผ๋กœ 2์‹œ๊ฐ„ ์ด๋‚ด ๋ฐœํ˜„, ์ฆ์ƒ์œผ๋กœ euphoria, ๊ณ ์กฐ๋œ ์ด๋ฏธ์ง€ํ™”, ์‹œ๊ฐ„๊ฐ๊ฐ ์ €ํ•˜, ํ™˜์‹œ๊ฐ€ ํ”ํ•˜๋‹ค
โ€ข
๋นˆ๋งฅ๊ณผ ๊ณ ํ˜ˆ์••์ด ์žˆ์„ ์ˆ˜ ์žˆ๊ณ , ๋ฐœ์—ด๊ณผ ๋ฐœ์ž‘์ด ๋“œ๋ฌผ๊ฒŒ ๋ณด๊ณ ๋œ ๊ฒฝ์šฐ๋„ ์žˆ๋‹ค
โ€ข
๋ณดํ†ต 4~6์‹œ๊ฐ„ ์ง€์†, ๊ธธ๊ฒŒ๋Š” 12์‹œ๊ฐ„๊นŒ์ง€ ์ง€์†๋˜๊ธฐ๋„ ํ•œ๋‹ค

(2) ์น˜๋ฃŒ

โ€ข
๊ธฐ๋ณธ์€ supportive treatment. ํ™˜์ž๋ฅผ ์–ด๋‘ก๊ณ  ์กฐ์šฉํ•œ ๋ฐฉ์— ๋‘๊ณ  ์‹œ๊ฐ ์ž๊ทน์„ ํ”ผํ•˜๋ฉฐ, ํ•„์š” ์‹œ sedation(benzodiazepine) ์„ ํ•œ๋‹ค.
โ€ข
Delirium์ด ์•…ํ™”๋  ์ˆ˜ ์žˆ์–ด anticholinergic agents ๋Š” ์ฃผ์ง€ ์•Š๋Š”๋‹ค.

C2. Isoxazole mushroom

(1) ์ฆ์ƒ

โ€ข
์„ญ์ทจ ํ›„ 30๋ถ„ ์ด๋‚ด์— muscarinic ์ค‘๋… ์ฆ์ƒ (์˜ค์‹ฌ, ๊ตฌํ† , ์„ค์‚ฌ, ํ˜ˆ๊ด€ํ™•์žฅ, ๋ฐœํ•œ, ํƒ€์•ก๋ถ„๋น„)์ด ๋‚˜ํƒ€๋‚˜๊ณ  30 ๋ถ„ ๋’ค์—๋Š” drowsiness, dizziness, photosensitivity, euphoria, motor hyperactivity, ataxia, ๋ถ„ ๋’ค์—๋Š” muscle jerking, hallucination, delirium(ํฌ๊ธฐ ์‹œ๊ฐ„ ์žฅ์†Œ์— ๋Œ€ํ•œ ์ธ์ง€์žฅ์• ) ๊ณผ ํ•จ๊ป˜ atropine-like symptom complex(์‚ฐ๋™, ๊ตฌ๊ฐ•๊ฑด์กฐ์ฆ, ์ฒด์˜จ์ƒ์Šน, ํ˜ˆ์••์ƒ์Šน)์˜ ์ฆ์ƒ์œผ๋กœ ๋Œ€์ฒด๋œ๋‹ค
โ€ข
๋ณดํ†ต ์„ญ์ทจํ•˜๊ณ  4~6 ์‹œ๊ฐ„ ํ›„ ์ €์ ˆ๋กœ ์ฆ์ƒ์ด ์†Œ์‹ค๋œ๋‹ค

(2) ์น˜๋ฃŒ

โ€ข
ํ™œ์„ฑํƒ„์„ ํˆฌ์—ฌํ•˜๊ณ , CNS depression๊ณผ seizure๋กœ ์ธ aspiration์˜ ์œ„ํ—˜์ด ์žˆ๊ธฐ ๋•Œ๋ฌธ์— ipecac syrup์€ ์ฃผ์ง€ ์•Š๋Š”๋‹ค
โ€ข
๊ตฌํ† ์™€ ์„ค์‚ฌ๊ฐ€ ์‹ฌํ•˜๋ฉด fluids์™€ electrolyte replace๋ฅผ ํ•œ๋‹ค
โ€ข
Agitation์€ ์ ์ ˆํžˆ restrainํ•˜๊ณ  sedation(benzodiazepine)์„ ํ•œ๋‹ค
โ€ข
Physostigmine(์„ฑ์ธ 1~2mg IV / ์†Œ์•„ 0.5mg IV)์€ ์„œ๋งฅ, ์ €ํ˜ˆ์••, ๋ฐœ์ž‘์„ ์œ ๋ฐœํ•  ์ˆ˜ ์žˆ๊ธฐ ๋•Œ๋ฌธ์— severe anticholinergic symptom์„ ๋ณด์ด๋Š” ํ™˜์ž์—๊ฒŒ๋งŒ ๊ณ ๋ คํ•  ์ˆ˜ ์žˆ๋‹ค

D Early onset muscarinic symptom

โ€ข
Muscarine์€ ์—ด์— ๊ฐ•ํ•˜๊ณ  cholinesterase์— ์˜ํ•ด ๋ถ„ํ•ด๋˜์ง€ ์•Š๊ธฐ ๋•Œ๋ฌธ์— ์ž‘์šฉ์‹œ๊ฐ„์ด ๊ธธ๋‹ค muscarine์„ ํ•จ์œ ํ•œ ๋ฒ„์„ฏ์€ neurologic symptomr๊ณผ muscarinic ํ˜น์€ cholinergic effect ๋ฅผ ์œ ๋ฐœํ•  ์ˆ˜ ์žˆ๋‹ค.

D1. ์ฆ์ƒ

โ€ข
SLUDGE : Salivation, Lacrimation, Urination, Defecation, GI hypermotility, Emesis
โ€ข
Diaphoresis, muscle fasciculation, miosis, bradycardia, bronchorrhea . ๋„ ๋‚˜ํƒ€๋‚  ์ˆ˜ ์žˆ๋‹ค
โ€ข
์„ญ์ทจ ํ›„ 3-๋ถ„ ๋‚ด์— ์ฆ์ƒ์ด ๋ฐœ์ƒํ•˜๋ฉฐ 4~12์‹œ๊ฐ„ ๋’ค์— ํ˜ธ์ „๋œ๋‹ค

D2. ์น˜๋ฃŒ

โ€ข
๋Œ€๋ถ€๋ถ„์˜ ๊ฒฝ์šฐmuscarinic ์ฆ์ƒ์€ ๊ฒฝํ•˜๊ณ  self-limited๋˜๊ณ , supportive care๋กœ ์ถฉ๋ถ„ํ•˜๋‹ค.

(1) Atropine(์„ฑ์ธ 0.5~1mg IV / ์†Œ์•„ 0.01mg/kg IV)

โ€ข
์ˆ˜์•ก ๊ณต๊ธ‰์—๋„ ๋ฐ˜์‘์ด ์—†๋Š” ์„œ๋งฅ๊ณผ ์ €ํ˜ˆ์••์„ ๋ณด์ด๋Š” ๊ฒฝ์šฐ ํšจ๊ณผ์ ์ผ ์ˆ˜ ์žˆ๋‹ค.
โ€ข
Diaphoresis, oral secretion, bronchorrhea, GI cramping, emesis, diarrhea ์น˜๋ฃŒ์— ๋„์›€์ด ๋  ์ˆ˜ ์žˆ๋‹ค.
โ€ข
Oxygen๊ณผ inhaled beta-agonist(albuterol)๊ฐ€ pulmonary secretion๊ณผ brochospasm ์น˜๋ฃŒ์— ๊ถŒ๊ณ ๋œ๋‹ค.

E. Delayed onset GI symptom

F. Delayed onset renal failure

1.
A.smithiana (์Šค๋ฏธ์Šค๊ด‘๋Œ€๋ฒ„์„ฏ)๋‚˜ cortinarius (๋ˆ์ ๋ฒ„์„ฏ ๋ฅ˜) ์„ญ์ทจ ํ›„ ๋ฐœ์ƒํ•œ๋‹ค.
2.
์—ด์— ๊ฐ•ํ•˜๋ฉฐ ์‹ ์žฅ์˜ ๋‹จ๋ฐฑํ•ฉ์„ฑ์„ ์ €ํ•ดํ•œ๋‹ค
3.
์กฐ์ง๊ฒ€์‚ฌ์—์„œ interstitial nephritis, tubular necrosis์†Œ๊ฒฌ์„ ๋ณด์ธ๋‹ค
4.
์ฆ์ƒ (1) ์ดˆ๊ธฐ์—๋Š” ๋ช‡ ์‹œ๊ฐ„์—์„œ ๋ฉฐ์น ์‚ฌ์ด์— GI Sx. ๋ฐœ์ƒํ•˜์—ฌ 3์ผ๊นŒ์ง€ ์ง€์†๋  ์ˆ˜ ์žˆ๋‹ค (2) 3~20์ผ๋‚ด ๋“ฑ์ด๋‚˜ ์˜†๊ตฌ๋ฆฌ ํ†ต์ฆ, oliguria ์™€ ๊ฐ™์€ renal failur์ฆ์ƒ ๋ฐœ์ƒํ•œ๋‹ค
5.
์น˜๋ฃŒ (1) ๋ณด์กด์  ์น˜๋ฃŒ, ํˆฌ์„ (2) ์ ์–ด๋„ 72์‹œ๊ฐ„ ๋™์•ˆ ์ „ํ•ด์งˆ์ด๋‚˜ ์‹ ๊ธฐ๋Šฅ์„ ๋ชจ๋‹ˆํ„ฐํ•œ๋‹ค

G. Delayed onset disulfiram reaction

1.
Coprinus(๋จน๋ฌผ๋ฒ„์„ฏ ๊ณ„์—ด) : coprine์ด๋ผ๋Š” ๋ฌผ์งˆ์„ ํ•จ์œ ํ•œ๋‹ค
2.
Coprine. ์„ ์„ญ์ทจํ•œ 2์‹œ๊ฐ„ ์•ˆ์— ์•Œ์ฝœ ๋ถ„ํ•ด๋ฅผ ์ €ํ•ดํ•˜๊ณ  72์‹œ๊ฐ„๊นŒ์ง€ ์ง€์†๋œ๋‹ค ๋”ฐ๋ผ์„œ ๋จน๋ฌผ๋ฒ„์„ฏ์„ ๋จน์€ ๋’ค ์•Œ์ฝœ ์„ญ์ทจํ•˜๋ฉด disulfiram reaction์ด๋ผ๋Š” ์ฆ์ƒ์„ ๋ณด์ด๋Š”๋ฐ, ๋‘ํ†ต ์‚ฌ์ง€ ๊ฐ๊ฐ์ด์ƒ,metalic taste, ํ™์กฐ, ๋‘๊ทผ๊ฑฐ๋ฆผ, ํ‰ํ†ต, ์˜ค์‹ฌ, ๊ตฌํ† , ๋ฐœํ•œ ๋“ฑ์˜ ์ฆ์ƒ์„ ๋ณด์ธ๋‹ค
3.
์ฆ์ƒ์€ ๋Œ€๊ฐœ 2~4 ์‹œ๊ฐ„ ๋™์•ˆ ์ง€์†๋˜์ง€๋งŒ 2์ผ๊ฐ€์ง€ ์ง€์†๋  ์ˆ˜๋„ ์žˆ๋‹ค
4.
Charcoal ์€ ํšจ๊ณผ๊ฐ€ ์—†๊ณ , hypotension์— IV fluid ๋ฅผ ํˆฌ์—ฌํ•˜๊ณ  refractory case์— norepinephrine์„ ํˆฌ์—ฌํ•œ๋‹ค. Excessive sympathetic activity์— ฮฒ -blocker์„ ์‚ฌ์šฉํ•  ์ˆ˜ ์žˆ๋‹ค
5.
Self-limitedํ•˜๊ณ  oral fluid์— tolerableํ•˜๋ฉด ํ‡ด์›ํ•œ๋‹ค

H. Shiitake dermatitis

1.
๋™์•„์‹œ์•„์—์„œ ํ”ํ•˜๋‹ค
2.
๋ฒ„์„ฏ ์„ญ์ทจ ํ›„ 1~2์ผ ์•ˆ์— ๋ฐœ์ƒํ•˜๋Š” ์ฑ„์ฐ๋งž์€ ๋ชจ์–‘์˜ flagellate erythema ๊ฐ€ ํŠน์ง•์œผ๋กœ whip-like linear wheal์ด๋‹ค. ๊ฐ€๋ ค์›€์ด ๋™๋ฐ˜๋˜๊ณ  erythema์˜ branching patch์™€ scattered petechia๊ฐ€ ๋ณด์ผ ์ˆ˜ ์žˆ๋‹ค
3.
์น˜๋ฃŒ๋Š” 0.1% triamcinolone ์—ฐ๊ณ ๋ฅผ ๋งค์ผ 2๋ฒˆ ์‚ฌ์šฉํ•˜๊ณ , oral antihistamine์„ ๋ณต์šฉํ•œ๋‹ค
4.
์น˜๋ฃŒํ•˜์ง€ ์•Š๋”๋ผ๋„ 1~4์ฃผ ๋‚ด ์ƒ‰์†Œ์นจ์ฐฉ ์—†์ด ๊ด€ํ•ด๋œ๋‹ค. ๋ฐ˜ํ”์ด๋‚˜ ํ›„์œ ์ฆ์€ ์•„์ง ๋ณด๊ณ ๋˜์ง€ ์•Š์•˜๋‹ค